About NeoGenix Biosciences

NeoGenix Biosciences builds the next generation of sperm selection and analysis tools for the IVF lab. Our commercial product, SpermSearch.AI, helps embryologists find viable sperm in severely compromised samples and testicular tissue — in use across 32 paying clinics in 10 countries, with A$300k+ ARR in under twelve months. Our second product, SpermGuide, is a microfluidic device with peer-reviewed evidence showing 82–92% reduction in DNA fragmentation versus standard of care.

🎯 The Problem

Male factor is implicated in roughly half of all infertility cases, yet the dominant sperm preparation technique — density gradient centrifugation — was developed in the 1980s and is now known to inflict significant DNA damage on the very cells embryologists most need to be healthy. In the hardest cases (cryptozoospermia, surgical testicular samples) embryologists can spend hours manually scanning slides for a handful of viable sperm, often unsuccessfully. The IVF lab toolkit hasn't materially changed in decades, even as the science has moved on.

💡 The Solution

SpermSearch.AI is an AI co-pilot for embryologists that scans samples and surfaces candidate sperm, dramatically cutting search time on the hardest cases — including testicular tissue. SpermGuide is a single-use microfluidic device that uses biomimetic flow to isolate high-DNA-integrity sperm without centrifugation; published clinical data shows an 82–92% reduction in DNA fragmentation versus standard DGC. Together they give IVF clinics a hardware-plus-software pathway to better outcomes for the patients existing techniques fail.

💰 Raise Details

👥 Team

Dr. Steven Vasilescu

Founder & CEO

Dr. Steven Vasilescu — Leading strategy, regulatory direction, and commercialisation across both product lines. Holds a PhD in Biomedical Engineering and dual degrees in Biotechnology and Mechanical Engineering from UTS, with doctoral research on high-throughput microfluidic platforms that forms the foundation of SpermGuide. Brings cross-sector experience in device design, microfluidics, and translating academic research into manufacturable, regulated products.

in

Dale Goss

CSO

Dale Goss — Clinical embryologist at IVF Australia (Virtus Health) and co-inventor of SpermSearchAI, leading all clinical validation, usability, and regulatory readiness activities at NeoGenix. Holds an MSc from Stellenbosch University and a Master of Clinical Embryology from Monash; currently a PhD candidate at UTS researching extracellular vesicles and male reproductive dysfunction. Over a decade of combined experience in clinical embryology and translational reproductive research, with multiple peer-reviewed publications and international conference presentations (ESHRE).

in